Making your voice heard when communicating with HCPs
David Barwick, Director of Client Solutions at Amplity Health, examines how in an ocean of data, how you can make sure that your voice...
CDMOs: consolidation, capabilities and customer demand
Mark Quick, VP Corporate Development at Recipharm, explains the three Cs: Consolidation, capabilities and customer demand. As we head into 2020, we expect to see...
The impact of technology on the future of medicine
Ruth Burns, Director of Corporate Communications & Stakeholder Relations at Thornton & Ross, looks at the impact of technology on the future of medicine. More...
2020: The NHS and what it means for pharma
Oli Hudson, Content Director at Wilmington Healthcare, looks at the year ahead for the NHS and what it means for pharma in 2020. Place-based care...
Replacing traditional brand management with multichannel interaction
Graham McIntosh, Managing Director of Commercial & Clinical Pharma, at Uniphar Group plc looks at how the traditional brand management approach isn’t working anymore...
Tillotts Pharma UK embracing partnerships
Jeremy Thorpe is Managing Director of Tillotts Pharma UK Ltd. In his seven years at the helm, he has seen continuous double-digit growth and...
Setting up a menopause support group
Angela Bandeira of Northumbria Healthcare Foundation Trust shares her experience of setting up a menopause support group. Why did you want to set up a...
Implementing Agile working in pharma
Neil Osmond asks whether the Agile mindset and approach to managing projects could solve the pharmaceutical industry’s productivity problem and discusses the benefits of...
Engaging patients earlier in clinical development
Successful patient engagement is essential to the clinical development process. How can companies get it right? Patient and public engagement in clinical research means that...
The five legal pitfalls of clinical trial agreements
Sarah Lynam discusses the five legal pitfalls of clinical trial agreements. Collaboration between pharmaceutical companies, research organisations and hospital trusts, and the resulting clinical trials...
Latest articles
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
CMA formally concludes fludrocortisone investigation
The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...